I note the variation in the expiry dates of the existing HAVO and those mentioned in today's announcement regarding the conversion of CUYO to HAVO. This implies that there will be 2 classes of listed options for HAVILAH. All sounds rather messy.
On the positive side I am relieved that there has been no dilution of the offer for the holders of CUY. Trading over the past week or two in CUY shares has been minimal and lower in price than just after the original announcement.
The sooner this is all concluded the better as far as I am concerned so that the company can concentrate on achieving a sale of Kalkaroo.
My sentiment is BUY any or all of the HAV/CUY shares and options.
- Forums
- ASX - By Stock
- CUY
- Ann: Variation of Takeover Bid
Featured News
Add CUY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online